Tenet Healthcare (THC) Stock Dips While Market Gains: Key Facts

Zacks
Zacks kaynağında aç
Tenet Healthcare (THC) Stock Dips While Market Gains: Key Facts

In the latest trading session, Tenet Healthcare (THC) closed at $269.13, marking a -1.17% move from the previous day. This change lagged the S&P 500's 0.58% gain on the day. At the same time, the Dow added 0.69%, and the tech-heavy Nasdaq gained 1.05%.

Coming into today, shares of the hospital operator had gained 3.92% in the past month. In that same time, the Medical sector gained 3.5%, while the S&P 500 gained 0.97%.

The investment community will be closely monitoring the performance of Tenet Healthcare in its forthcoming earnings report. The company is scheduled to release its earnings on October 29, 2026. The company is predicted to post an EPS of $4.59, indicating a 24.05% growth compared to the equivalent quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $5.47 billion, reflecting a 3.34% rise from the equivalent quarter last year.

For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $21.04 per share and a revenue of $22.2 billion, representing changes of +25.39% and +4.18%, respectively, from the prior year.

Investors might also notice recent changes to analyst estimates for Tenet Healthcare. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, there's been a 0.02% fall in the Zacks Consensus EPS estimate. Tenet Healthcare is currently sporting a Zacks Rank of #3 (Hold).

From a valuation perspective, Tenet Healthcare is currently exchanging hands at a Forward P/E ratio of 12.95. This valuation marks no noticeable deviation compared to its industry average Forward P/E of 12.95.

One should further note that THC currently holds a PEG ratio of 1.04. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Medical - Hospital stocks are, on average, holding a PEG ratio of 1.15 based on yesterday's closing prices.

The Medical - Hospital industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 197, positioning it in the bottom 20% of all 250+ industries.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Tenet Healthcare Corporation (THC): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research